Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP (2008) Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab 93(1):61–67. https://doi.org/10.1210/jc.2007-1191

Article  CAS  PubMed  Google Scholar 

Wassenaar MJ, Biermasz NR, Kloppenburg M, van der Klaauw AA, Tiemensma J, Smit JW, Pereira AM, Roelfsema F, Kroon HM, Romijn JA (2010) Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients. Growth Horm IGF Res 20(3):226–233. https://doi.org/10.1016/j.ghir.2010.02.003

Article  CAS  PubMed  Google Scholar 

Wassenaar MJ, Biermasz NR, van Duinen N, van der Klaauw AA, Pereira AM, Roelfsema F, Smit JW, Kroon HM, Kloppenburg M, Romijn JA (2009) High prevalence of arthropathy, according to the definitions of radiological and clinical osteoarthritis, in patients with long-term cure of acromegaly: a case-control study. Eur J Endocrinol 160(3):357–365. https://doi.org/10.1530/eje-08-0845

Article  CAS  PubMed  Google Scholar 

Cushing H (1909) Partial hypophysectomy for acromegaly: with remarks on the function of the hypophysis. Ann Surg 50(6):1002–1017. https://doi.org/10.1097/00000658-190912000-00003

Article  CAS  PubMed  PubMed Central  Google Scholar 

Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102–152. https://doi.org/10.1210/er.2002-0022

Article  CAS  PubMed  Google Scholar 

Biermasz NR, Pereira AM, Smit JW, Romijn JA, Roelfsema F (2005) Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab 90(5):2731–2739. https://doi.org/10.1210/jc.2004-2297

Article  CAS  PubMed  Google Scholar 

Giustina A (2023) Acromegaly and bone: an update. Endocrinol Metab 38(6):655–666. https://doi.org/10.3803/EnM.2023.601

Article  CAS  Google Scholar 

Mazziotti G, Lania AG, Canalis E (2022) Skeletal disorders associated with the growth hormone-insulin-like growth factor 1 axis. Nat Rev Endocrinol 18(6):353–365. https://doi.org/10.1038/s41574-022-00649-8

Article  CAS  PubMed  Google Scholar 

Wassenaar MJ, Biermasz NR, Bijsterbosch J, Pereira AM, Meulenbelt I, Smit JW, Roelfsema F, Kroon HM, Romijn JA, Kloppenburg M (2011) Arthropathy in long-term cured acromegaly is characterised by osteophytes without joint space narrowing: a comparison with generalised osteoarthritis. Ann Rheum Dis 70(2):320–325. https://doi.org/10.1136/ard.2010.131698

Article  CAS  PubMed  Google Scholar 

Claessen KM, Ramautar SR, Pereira AM, Smit JW, Roelfsema F, Romijn JA, Kroon HM, Kloppenburg M, Biermasz NR (2012) Progression of acromegalic arthropathy despite long-term biochemical control: a prospective, radiological study. Eur J Endocrinol 167(2):235–244. https://doi.org/10.1530/eje-12-0147

Article  CAS  PubMed  Google Scholar 

Claessen KM, Ramautar SR, Pereira AM, Romijn JA, Kroon HM, Kloppenburg M, Biermasz NR (2014) Increased clinical symptoms of acromegalic arthropathy in patients with long-term disease control: a prospective follow-up study. Pituitary 17(1):44–52. https://doi.org/10.1007/s11102-013-0464-6

Article  CAS  PubMed  Google Scholar 

Pelsma ICM, Biermasz NR, van Furth WR, Pereira AM, Kroon HM, Kloppenburg M, Claessen K (2020) Progression of acromegalic arthropathy in long-term controlled acromegaly patients: 9 years of longitudinal follow-up. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgaa747

Article  Google Scholar 

Pelsma ICM, Kroon HM, van Trigt VR, Pereira AM, Kloppenburg M, Biermasz NR, Claessen K (2022) Clinical and radiographic assessment of peripheral joints in controlled acromegaly. Pituitary. https://doi.org/10.1007/s11102-022-01233-z

Article  PubMed  PubMed Central  Google Scholar 

Barkan, A.: Acromegalic arthropathy and sleep apnea. J Endocrinol 155 Suppl 1, S41–44; discussion S45 (1997).

Barkan AL (2001) Acromegalic arthropathy. Pituitary 4(4):263–264

Article  CAS  PubMed  Google Scholar 

Colao A, Cannavo S, Marzullo P, Pivonello R, Squadrito S, Vallone G, Almoto B, Bichisao E, Trimarchi F, Lombardi G (2003) Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly. Eur J Endocrinol 148(1):31–38

Article  CAS  PubMed  Google Scholar 

Colao A, Marzullo P, Vallone G, Giaccio A, Ferone D, Rossi E, Scarpa R, Smaltino F, Lombardi G (1999) Ultrasonographic evidence of joint thickening reversibility in acromegalic patients treated with lanreotide for 12 months. Clin Endocrinol 51(5):611–618

Article  CAS  Google Scholar 

Claessen KM, Kloppenburg M, Kroon HM, Romijn JA, Pereira AM, Biermasz NR (2013) Two phenotypes of arthropathy in long-term controlled acromegaly? A comparison between patients with and without joint space narrowing (JSN). Growth Horm IGF Res 23(5):159–164. https://doi.org/10.1016/j.ghir.2013.05.003

Article  CAS  PubMed  Google Scholar 

Nakagawa Y, Hyakuna K, Otani S, Hashitani M, Nakamura T (1999) Epidemiologic study of glenohumeral osteoarthritis with plain radiography. J Shoulder Elbow Surg 8(6):580–584. https://doi.org/10.1016/s1058-2746(99)90093-9

Article  CAS  PubMed  Google Scholar 

Ansok CB, Muh SJ (2018) Optimal management of glenohumeral osteoarthritis. Orthop Res Rev 10:9–18. https://doi.org/10.2147/ORR.S134732

Article  PubMed  PubMed Central  Google Scholar 

Ibounig T, Simons T, Launonen A, Paavola M (2020) Glenohumeral osteoarthritis: an overview of etiology and diagnostics. Scand J Surg. https://doi.org/10.1177/1457496920935018

Article  PubMed  Google Scholar 

Oh JH, Chung SW, Oh CH, Kim SH, Park SJ, Kim KW, Park JH, Lee SB, Lee JJ (2011) The prevalence of shoulder osteoarthritis in the elderly Korean population: association with risk factors and function. J Shoulder Elbow Surg 20(5):756–763. https://doi.org/10.1016/j.jse.2011.01.021

Article  PubMed  Google Scholar 

Prencipe N, Scarati M, Manetta T, Berton AM, Parisi S, Bona C, Parasiliti-Caprino M, Ditto MC, Gasco V, Fusaro E, Grottoli S (2020) Acromegaly and joint pain: is there something more? A cross-sectional study to evaluate rheumatic disorders in growth hormone secreting tumor patients. J Endocrinol Invest 43(11):1661–1667. https://doi.org/10.1007/s40618-020-01268-8

Article  CAS  PubMed  Google Scholar 

Pelsma ICM, van Trigt VR, Kroon HM, Pereira AM, van der Meulen C, Kloppenburg M, Biermasz NR, Claessen KMJA (2021) Low prevalence of neuropathic-like pain symptoms in long-term controlled acromegaly. Pituitary. https://doi.org/10.1007/s11102-021-01190-z

Article  PubMed  PubMed Central  Google Scholar 

Wassenaar M, Biermasz N, Kloppenburg M, van der Klaauw A, Tiemensma J, Smit J, Pereira A, Roelfsema F, Kroon H, Romijn J (2010) Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients. Growth Hormon IGF Res 20:226–233

Article  CAS  Google Scholar 

Pelsma ICM, Kroon HM, van Trigt VR, Pereira AM, Kloppenburg M, Biermasz NR, Claessen K (2022) Clinical and radiographic assessment of peripheral joints in controlled acromegaly. Pituitary 25(4):622–635. https://doi.org/10.1007/s11102-022-01233-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MA, te Velde A, Verrips E (1998) Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 51(11):1055–1068. https://doi.org/10.1016/s0895-4356(98)00097-3

Article  CAS  PubMed  Google Scholar 

Brazier JE, Harper R, Jones NM, O’Cathain A, Thomas KJ, Usherwood T, Westlake L (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305(6846):160–164. https://doi.org/10.1136/bmj.305.6846.160

Article  CAS  PubMed  PubMed Central  Google Scholar 

Webb SM, Prieto L, Badia X, Albareda M, Catala M, Gaztambide S, Lucas T, Paramo C, Pico A, Lucas A, Halperin I, Obiols G, Astorga R (2002) Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin Endocrinol (Oxf) 57(2):251–258.